LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis.

    Jayant, Kumar / Reccia, Isabella / Virdis, Francesco / Pyda, Jordan S / Bachul, Piotr J / di Sabato, Diego / Barth, Rolf N / Fung, John / Baker, Talia / Witkowski, Piotr

    Clinical transplantation

    2021  Volume 35, Issue 4, Page(s) e14246

    Abstract: ... among hospitalized LTx recipients with COVID-19. A database search of literature published between December 1, 2019 ... recipients with COVID-19 had a high prevalence of dyspnea and gastrointestinal symptoms ... Adverse clinical outcomes related to SARS-CoV-2 infection among liver transplant (LTx) recipients ...

    Abstract Adverse clinical outcomes related to SARS-CoV-2 infection among liver transplant (LTx) recipients remain undefined. We performed a meta-analysis to determine the pooled prevalence of outcomes among hospitalized LTx recipients with COVID-19. A database search of literature published between December 1, 2019, and November 20, 2020, was performed per PRISMA guidelines. Twelve studies comprising 517 hospitalized LTx recipients with COVID-19 were analyzed. Common presenting symptoms were fever (71%), cough (62%), dyspnea (48%), and diarrhea (28%). Approximately 77% (95% CI, 61%-93%) of LTx recipients had a history of liver cirrhosis. The most prevalent comorbidities were hypertension (55%), diabetes (45%), and cardiac disease (21%). In-hospital mortality was 20% (95% CI, 13%-28%) and rose to 41% (95% CI, 19%-63%) (P < 0.00) with ICU admission. Additional subgroup analysis demonstrated a higher mortality risk in the elderly (>60-65 years) (OR 4.26; 95% CI, 2.14-8.49). There was no correlation in respect to sex or time since transplant. In summary, LTx recipients with COVID-19 had a high prevalence of dyspnea and gastrointestinal symptoms. In-hospital mortality was comparable to non-transplant populations with similar comorbidities but appeared to be less than what is reported elsewhere for cirrhotic patients (26%-40%). Importantly, the observed high case fatality in the elderly could be due to age-associated comorbidities.
    MeSH term(s) Aged ; Aged, 80 and over ; COVID-19/epidemiology ; Carcinoma, Hepatocellular/surgery ; Female ; Hospitalization ; Humans ; Liver Neoplasms/surgery ; Liver Transplantation ; Male ; Middle Aged ; Transplant Recipients
    Language English
    Publishing date 2021-02-25
    Publishing country Denmark
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 639001-8
    ISSN 1399-0012 ; 0902-0063
    ISSN (online) 1399-0012
    ISSN 0902-0063
    DOI 10.1111/ctr.14246
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: COVID-19 in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis of Current Literature

    Raja, Mohammed A. / Mendoza, Maria A. / Villavicencio, Aasith Anjan Shweta Reynolds John M. / Kittipibul, Veraprapas Fernandez Anmary Guerra Giselle Camargo Jose F. / Simkins, Jacques Morris Michele I. / Abbo, Lilian A. / Natori, Yoichiro

    Transplantation Reviews

    Abstract: ... for systematic review and 60 for meta-analysis We identified 2,772 unique SOT recipients including 1,500 kidney ... meta-analysis of SOT recipients with SARS-CoV-2 infection from January 1st t October 9th, 2020 Pooled incidence ... studies in solid organ transplant (SOT) recipients suggested a wide variety of presentations ...

    Abstract Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic Early studies in solid organ transplant (SOT) recipients suggested a wide variety of presentations, however, there remains a paucity of robust data in this population We conducted a systematic review and meta-analysis of SOT recipients with SARS-CoV-2 infection from January 1st t October 9th, 2020 Pooled incidence of symptoms, treatments and outcomes were assessed Two hundred and fifteen studies were included for systematic review and 60 for meta-analysis We identified 2,772 unique SOT recipients including 1,500 kidney, 505 liver, 141 heart and 97 lung Most common presenting symptoms were fever and cough in 70 2% and 63 8% respectively Majority (81%) required hospital admission Immunosuppressive medications, especially antimetabolites, were decreased in 76 2% Hydroxychloroquine and interleukin six antagonists were administered in59 5% and 14 9% respectively, while only few patients received remdesivir and convalescent plasma Intensive care unit admission was 29% from amongst hospitalized patients Only few studies reported secondary infections Overall mortality was 18 6% Our analysis shows a high incidence of hospital admission in SOT recipients with SARS-CoV-2 infection As management of SARS-CoV-2 continues to evolve, long-term outcomes among SOT recipients should be assessed in future studies
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #922148
    Database COVID19

    Kategorien

To top